Few exercises in clinical medicine are more troublesome than securing a diagnosis of pulmonary embolism. Because of the protean clinical features of pulmonary embolism, much reliance has been placed on the direct and indirect imaging of clot within the pulmonary arteries and/or peripheral venous system. This has prompted the cynical observation that radiologists and other imagers devise tests of dubious value faster than clinicians can discard them. Increasingly elaborate diagnostic algorithms have been recommended, which in reality are seldom followed. The ideal diagnostic test would reliably and safely show clot within the pulmonary arteries. Pulmonary arteriography is regarded as the final arbiter, simply because it directly images embolus within the pulmonary arteries. The assumption that life threatening emboli are not missed by pulmonary arteriography seems to hold true.'2 However, it is worth assaying this gold standard from time to time; although false positives are difficult to prove and probably scarce, false negatives can occur despite extensive intravascular thrombus. 3 In the UK ventilation-perfusion (V/Q) scanning is more widely available than pulmonary arteriography. The PIOPED study2 has shown that, when the suspicion of pulmonary embolism is high, based on clinical and laboratory findings, and the V/Q scan is in the high probability category, the chance of a positive pulmonary arteriogram exceeds 95%. At V/Q scan. Forty two patients who had a non-diagnostic V/Q scan (defined as neither normal nor high probability) also underwent pulmonary arteriography in addition to the three patients who had a high probability V/Q scan but no evidence of emboli on the CVCT scan. Patients who had a normal V/Q scan were not investigated further. In the group of patients with non-diagnostic V/Q scans and the three patients with high probability V/Q scans but no confirmation of embolism by CT scanning, CVCT scanning (using pulmonary arteriography as the gold standard) had a sensitivity of 83% and a specificity of 97%. There was one false positive and one false negative CVCT scan. Two patients had both a negative CVCT scan and negative arteriogram. Replacing the pulmonary arteriogram with CVCT scanning in this group of patients would have resulted in failure to diagnose pulmonary embolism in two patients and an erroneous positive diagnosis in one.
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Ultrasonography of the lower limbs revealed deep vein thrombosis in 12 patients, all of whom had had high probability V/Q scans and positive CVCT scans. Thus compression ultrasonography as the next investigation in all patients with abnormal V/Q scans would have made further investigation unnecessary in only 12 out of 77 (16%) cases.
In this study the performance of CVCT scanning compared with pulmonary arteriography, particularly its low false negative rate, appears impressive. The false positive rate of CVCT scanning remains unknown and interobserver variation is also uncertain, but since a positive diagnosis relies simply on the identification of an intravascular filling defect, it is likely to be similar to pulmonary arteriography. The overall agreement between CVCT scanning and pulmonary arteriography in making the diagnosis of pulmonary embolism was good, but it would be reassuring to know that the filling defects representing pulmonary embolus correlated, defect for defect, between the two techniques. It is interesting that the authors felt it necessary to give pulmonary arteriography (the gold standard) a helping hand by interpreting the arteriograms in conjunction with the CVCT and V/Q scans.
The idea that CVCT scanning can be interposed between an indeterminate perfusion scan and pulmonary arteriography and so cut out the need for a ventilation scan raises the spectre of yet another unwieldy diagnostic flow chart. The most important question is in which situations, if any, can CVCT replace V/Q scanning and/or pulmonary arteriography. In a recent small series'2 the sensitivity of CVCT scanning for the presence of clot in the central pulmonary arteries was 86% and the specificity was 92%, in line with other series.813 However, when subsegmental vessels were included in the analysis these values fell to 63% and 89%, respectively. The conclusion was that clot in the subsegmental vessels demonstrated on pulmonary arteriography is not always reliably detected by CVCT scanning. The clinical importance of clot confined to subsegmental vessels is unknown. Whether refinements in CVCT technique can significantly improve the detection of emboli in small pulmonary arteries remains to be seen.
CVCT scanning offers two major advantages over all other non-invasive imaging tests. Firstly, it directly images intra-arterial clot whereas other tests (plain chest radiography, V/Q scanning, compression ultrasonography of the lower limb) mentioned in a recent review4 supply only indirect evidence of pulmonary embolism. Secondly, in contrast to pulmonary arteriography, CVCT scanning gives a bigger picture than the inside of the pulmonary arteries; as van Rossum et al have shown, this is not a diagnostic luxury. In the group with non-diagnostic V/Q scans, CVCT scanning showed other abnormalities in 24 of 42 patients which, in most cases, were likely to account for the patients' symptoms and signs. Even in patients with high probability V/Q scans the diagnosis of pulmonary embolism was refuted by CVCT scanning in two of 35 cases (both with subsequent negative pulmonary arteriograms). Interestingly, signs of pulmonary infarction were present in nearly one third of the patients with high probability V/Q scans.
The ability to scan a large part of the pulmonary arterial tree in a single breath hold, with optimal contrast opacification, is crucial to the success of CVCT scanning in detecting pulmonary emboli. Further potential improvements include targeted reconstruction which would increase the spatial resolution of small areas of the pulmonary arterial tree, multiplanar reformations which might aid interpretation, and larger single breath hold scan volumes.
No matter how accurate a test is, it will be used in clinical practice only if it is readily available. In this respect, pulmonary arteriography is wanting in the UK, being available in only about one third of acute hospitals.'4 Even if the earlier promises of magnetic resonance pulmonary arteriography are fulfilled,'5 16 the severe shortage of magnetic resonance machine time in the UK rules out this technique for the time being. CT scanners are widely available and an increasing number of machines have continuous volume scanning capability. For this reason alone, further evaluation of the accuracy and economics of CVCT scanning in pulmonary embolism is needed. It would be premature to predict how CVCT scanning will be used in the diagnosis of pulmonary embolism, but a multicentre European trial just underway should help to establish whether it is the imaging technique of choice or just another imperfect test.
